Form 8-K - Current report:
SEC Accession No. 0000950170-25-051663
Filing Date
2025-04-07
Accepted
2025-04-07 17:00:09
Documents
13
Period of Report
2025-04-01
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eldn-20250401.htm   iXBRL 8-K 50646
2 EX-16.1 eldn-ex16_1.htm EX-16.1 11181
3 GRAPHIC img58073241_0.jpg GRAPHIC 19320
  Complete submission text file 0000950170-25-051663.txt   204542

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20250401.xsd EX-101.SCH 24852
15 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20250401_htm.xml XML 4703
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 25818867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)